Boehringer Ingelheim
Tracked across 18 events · 144 articles · First seen Dec 19, 2025 · Last active Aug 19, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: Boehringer Ingelheim is expanding its global Computational Innovation footprint with a new AI and machine learning center in London, investing £150 million over 10 years to advance pharmaceutical R&D.
Apr 20, 2026 · 6 articles
Business
Impact: Boehringer Ingelheim entered into a global licensing agreement with Immunitas Therapeutics for a preclinical antibody program, strengthening its immunology pipeline and expanding its portfolio in autoimmune and inflammatory diseases.
May 12, 2026 · 6 articles
Tech
Impact: Boehringer Ingelheim is the sponsor and developer of BI 3034701; the Phase II trial advances its obesity pipeline, potentially enhancing its market position in the obesity treatment space.
Jul 16, 2026 · 6 articles
Business
Impact: Boehringer Ingelheim has entered into a partnership with Sequent Scientific — Alivira Animal Health Limited to expand its sales capabilities and market reach for companion animal products in India.
Jan 22, 2026 · 6 articles
Business
Impact: Boehringer Ingelheim India Private Limited signed an MoU with NIPER Hajipur to advance pharmaceutical research and education, providing access to its opnMe® platform and strengthening its commitment to India's pharmaceutical education network.
Apr 23, 2026 · 6 articles
Tech
Impact: Boehringer Ingelheim is collaborating with Suzhou Ribo Life Science Company on the MASH siRNA program, which has reached a significant milestone, advancing its pipeline for liver disease treatments.
May 06, 2026 · 7 articles
Regulatory
Impact: Boehringer Ingelheim's HERNEXEOS received FDA approval with Guardant360 CDx as its companion diagnostic, marking a significant step in bringing a new targeted therapy to market for HER2-mutant NSCLC patients.
Jun 11, 2026 · 7 articles
Business
Impact: Boehringer Ingelheim is a key player in the antibody therapeutics market, benefiting from the projected market growth.
Jul 28, 2026 · 6 articles
Accidents
Bluetongue serotype 3 (BTV-3), a potentially fatal livestock disease, has been detected on a third farm in Scotland — Dumfries and Galloway, United Kingdom — Scotland. The first case in United Kingdom — Scotland was…
Impact: Acknowledged farmer concerns and is working to secure additional bluetongue vaccine supplies. Increased vaccine demand could boost its revenue.
Aug 11, 2026 · 24 articles
Business
Impact: Boehringer Ingelheim is advertising for kidney disease screening with celebrity endorsements, participating in the health and telehealth advertising trend.
Feb 04, 2026 · 6 articles
Business
Impact: Boehringer Ingelheim participated in the symposium, showing its engagement in green chemistry initiatives.
Jul 20, 2026 · 6 articles
Tech
Cumulus Neuroscience announced the publication of final results from its CNS-102 study in Scientific Reports, demonstrating that its at-home NeuLogiq Platform is feasible, well tolerated, and highly usable for multimodal cognitive assessment in people living…
Impact: Boehringer Ingelheim is a consortium member. The study's findings could support its use of the NeuLogiq platform in future CNS trials.
Aug 18, 2026 · 6 articles
Tech
Impact: Boehringer Ingelheim provided support for the global awareness survey and the development of materials sharing its results.
May 05, 2026 · 7 articles
International
Impact: Boehringer Ingelheim managers are traveling with Friedrich Merz, indicating a focus on deepening cooperation in the pharmaceuticals sector with India.
Jan 11, 2026 · 6 articles
Tech
A large U.S. study published in the journal Gastro Hep Advances found that daily consumption of sugar-sweetened beverages is associated with a more than doubled risk of stomach (gastric) cancer. Researchers from the Mass General…
Impact: Andrew T. Chan served as a consultant; no direct impact.
Aug 17, 2026 · 20 articles
70
Boehringer Ingelheim working to secure vaccine supplies United KingdomBluetongue spreads to...
60
Boehringer Ingelheim working with regulators United Kingdom — Department for Environment, Food and Rural AffairsBluetongue spreads to...
10
Andrew T. Chan served as consultant Boehringer IngelheimSugary Drinks Linked to...
ERGEN INTELLIGENCE
Track Boehringer Ingelheim live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard